Updated ALEX Trial Results Show Alectinib Further Outpacing Crizotinib in Treatment Naive ALK+ NSCLC
Dpdated data further consolidate alectinib as the standard-of-care for first-line treatment of ALK+ non-small cell lung cancer.
3-Jun-2018 7:05 AM EDT Add to Favorites
Study published today the journal Cancer recommends colorectal cancer screening start at age 45, five years younger than currently recommended for both men and women of all races and ethnicities.
30-May-2018 11:05 AM EDT Add to Favorites
University of Colorado Cancer Center study shows that stereotactic body radiation (SBRT) may be better against anaplastic thyroid cancer, and with fewer side effects.
21-May-2018 11:05 AM EDT Add to Favorites
CU researchers mine data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid cancers, showing genetic alterations, and "high mutation burden" that is an FDA-approved marker for immunotherapy.
26-Apr-2018 1:05 PM EDT Add to Favorites
Global ROS1 Initiative Combines Patient Experience with Researcher Expertise to Target ROS1 Cancer Wherever It Grows
University of Colorado Cancer Center study presented at AACR 2018 describes new model for patient-researcher collaboration organized not around cancer type but around oncogene that causes many cancers
9-Apr-2018 12:00 PM EDT Add to Favorites
CU Cancer Center study presented at AACR18 shows that TIM3 and/or increased regulatory T cells (Tregs) within a tumor may help cancers inactivate immune system killer T cells that would otherwise identify and attack the cancer.
9-Apr-2018 1:05 PM EDT Add to Favorites
When prostate cancer metastasizes to bone, it can become especially dangerous – CU Cancer Center study at AACR18 hints at why: Cells involved in these bone metastases may release signals that drive the progression of the disease.
9-Apr-2018 2:05 PM EDT Add to Favorites
University of Colorado Cancer Center study presented at AACR 2018 shows that even within three days of treatment, melanoma cells find a way to activate MEK – not with mutations, but with a more flexible and temporary way to allow these cancer...
9-Apr-2018 3:05 PM EDT Add to Favorites
see all news
27-Jul-2015 11:05 AM EDT
An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT